Impact BioMedical, Inc. (IBO)
0.4437
0.00 (0.00%)
USD |
NYAM |
Aug 28, 16:00
Impact BioMedical Total Return Price : 0.4437 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 28, 2026 | 0.4437 |
| August 27, 2026 | 0.441 |
| August 26, 2026 | 0.4401 |
| August 25, 2026 | 0.4602 |
| August 24, 2026 | 0.453 |
| August 21, 2026 | 0.48 |
| August 20, 2026 | 0.4493 |
| August 19, 2026 | 0.4332 |
| August 18, 2026 | 0.47 |
| August 17, 2026 | 0.4774 |
| August 14, 2026 | 0.4593 |
| August 13, 2026 | 0.44 |
| August 12, 2026 | 0.447 |
| August 11, 2026 | 0.43 |
| August 10, 2026 | 0.4355 |
| August 07, 2026 | 0.4351 |
| August 06, 2026 | 0.4508 |
| August 05, 2026 | 0.43 |
| August 04, 2026 | 0.44 |
| August 03, 2026 | 0.439 |
| July 31, 2026 | 0.43 |
| July 30, 2026 | 0.43 |
| July 29, 2026 | 0.4265 |
| July 28, 2026 | 0.43 |
| July 27, 2026 | 0.432 |
| Date | Value |
|---|---|
| July 24, 2026 | 0.44 |
| July 23, 2026 | 0.4303 |
| July 22, 2026 | 0.4303 |
| July 21, 2026 | 0.441 |
| July 20, 2026 | 0.445 |
| July 17, 2026 | 0.456 |
| July 16, 2026 | 0.456 |
| July 15, 2026 | 0.46 |
| July 14, 2026 | 0.48 |
| July 13, 2026 | 0.463 |
| July 10, 2026 | 0.442 |
| July 09, 2026 | 0.4525 |
| July 08, 2026 | 0.4517 |
| July 07, 2026 | 0.4517 |
| July 06, 2026 | 0.477 |
| July 02, 2026 | 0.472 |
| July 01, 2026 | 0.484 |
| June 30, 2026 | 0.46 |
| June 29, 2026 | 0.5033 |
| June 26, 2026 | 0.471 |
| June 25, 2026 | 0.476 |
| June 24, 2026 | 0.4977 |
| June 23, 2026 | 0.5379 |
| June 22, 2026 | 0.5321 |
| June 18, 2026 | 0.5022 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Enveric Biosciences, Inc. | 1.37 |
| LENZ Therapeutics, Inc. | 5.11 |
| ANI Pharmaceuticals, Inc. | 72.83 |
| Corcept Therapeutics, Inc. | 113.88 |
| Veru, Inc. | 2.625 |